PIRS – pieris pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development to Support Phase 3 Single-Arm, Baseline-Controlled Trial in Microcystic Lymphatic Malformations [Yahoo! Finance]
PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders
Pieris Pharmaceuticals Second Quarter 2024 Earnings: US$2.76 loss per share (vs US$3.63 profit in 2Q 2023) [Yahoo! Finance]
We're A Little Worried About Pieris Pharmaceuticals' (NASDAQ:PIRS) Cash Burn Rate [Yahoo! Finance]
Form S-4/A PIERIS PHARMACEUTICALS,
Form S-4/A PIERIS PHARMACEUTICALS,
Form 4 PIERIS PHARMACEUTICALS, For: Aug 07 Filed by: GERAGHTY JAMES A
Form 425 PIERIS PHARMACEUTICALS, Filed by: PIERIS PHARMACEUTICALS, INC.
Form S-4/A PIERIS PHARMACEUTICALS,
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.